GLP-1 Fatigue: Tired on Ozempic or Zepbound?

GLP-1 fatigue is real, but it is usually less about the drug itself and more about what changes around it: you are eating far less, often drinking less, and sometimes losing muscle, all of which sap energy. Fatigue was reported in roughly 8 to 11 percent of people in semaglutide clinical trials, yet for most the bigger drivers are the steep drop in calories and carbs, dehydration, and falling short on protein. The fix usually starts with fueling and hydration, not just more rest.

This guide breaks down why you feel tired on a GLP-1, how to tell ordinary fatigue from a possible muscle-loss signal, and what actually restores energy.

Is the fatigue from the drug?

Partly, sometimes. Fatigue is listed as a side effect in GLP-1 clinical trials, reported in approximately 8 to 11 percent of people on semaglutide (Ozempic, Wegovy) and as a common adverse event with tirzepatide (Mounjaro, Zepbound), per the prescribing information and pooled trial data. So yes, some of it can be a direct effect, and it tends to be most noticeable during dose increases, easing as your body adjusts.

But "it's the drug" is rarely the whole story, and it is the least actionable explanation. Researchers describe GLP-1 fatigue as multifactorial, meaning several things stack up at once. The good news is that most of those things are things you can change.

The more likely culprits: under-fueling and dehydration

When a GLP-1 suppresses your appetite, your intake can drop dramatically and fast. That is the point, but it has side effects beyond weight loss.

Too few calories and carbs. A sharp, sustained calorie deficit leaves you with less fuel to run on, and very low carbohydrate intake in particular can flatten your energy and your workouts. Early on a GLP-1, it is easy to eat so little that fatigue is almost guaranteed.

Dehydration. Reduced appetite usually means you drink less too, and GI side effects like nausea, vomiting, or diarrhea compound the fluid loss. Dehydration mimics fatigue and weakness almost perfectly, which is why it muddies the picture so often. Electrolytes (sodium, potassium, magnesium) matter as much as plain water here. Our guide to dehydration and electrolytes on a GLP-1 digs into this, but the short version is that being even mildly under-hydrated can feel exactly like the drug is wiping you out.

Not enough protein. Protein is easy to undershoot when you are barely hungry, and chronically low protein leaves you feeling weak and depleted. It also sets up the next, more serious possibility.

These three are worth ruling in or out first, because they are common, they overlap, and they are fixable within days.

When fatigue might mean muscle loss

Here is the angle most articles skip. Rapid weight loss on a GLP-1 does not come only from fat. Research suggests roughly 25 to 40 percent of the weight lost on these medications can come from lean mass, a category that includes skeletal muscle along with water and organ mass (tirzepatide trials trend toward the lower end near 25 percent, while some semaglutide trials approach 40 percent). When you lose muscle, you do not just get smaller; you get weaker, you recover more slowly, and your energy can drop.

This is why persistent fatigue deserves a second look. If your tiredness comes with falling strength (lifts feeling heavier, grip weakening, stairs feeling harder) and you have been under-eating protein, that pattern points more toward muscle loss than a passing drug side effect. Our guide to the signs you're losing muscle on a GLP-1 walks through the full list, and why GLP-1s cause muscle loss explains the mechanism: it is not that the drug targets muscle, but that rapid loss plus suppressed protein intake plus no training stimulus gives your body little reason to defend it.

The reason this matters so much is that the same under-eating that drains your energy is also what threatens your muscle, and both improve with the same fix: more protein. To be clear, fatigue has many possible causes, and muscle loss is only one; sudden or severe fatigue, or fatigue that does not budge with better fueling, warrants a medical check to rule out anemia, thyroid issues, low B12, or other causes a clinician should evaluate.

How to get your energy back

The playbook for GLP-1 fatigue is mostly about fueling smarter, not resting more.

Hit your protein target. A common evidence-based target during weight loss is about 1.2 to 1.6 grams of protein per kilogram of body weight per day, per a 2025 joint advisory from the Obesity Medicine Association, The Obesity Society, the American Society for Nutrition, and the American College of Lifestyle Medicine. Protein protects muscle and supports energy, and it is the single highest-leverage habit here. If appetite is the obstacle, our guide on how much protein on a GLP-1 shows how to set and hit the number even when you are barely hungry.

Stay hydrated, with electrolytes. Make fluids a deliberate habit rather than waiting until you feel thirsty, and include electrolytes, especially on days with GI symptoms or harder workouts.

Do not let calories crater. A deficit is necessary for weight loss, but an extreme one is counterproductive and exhausting. Eating too little is a common, fixable cause of feeling wiped out.

Keep resistance training. It seems backwards when you are tired, but resistance training is the signal that tells your body to hold onto muscle in a deficit, and most people find it lifts energy rather than draining it. The 2025 advisory recommends at least three strength sessions a week alongside protein. See resistance training on a GLP-1 for a simple approach.

Protect your sleep. GI symptoms and reflux can fragment sleep early in treatment, which feeds daytime fatigue. Smaller, earlier evening meals help on both fronts.

Tracking tells the two apart

This is where logging earns its place, because "I'm tired" is a feeling, and feelings are hard to act on. Energy, protein, and strength are numbers, and numbers reveal patterns.

This is Myo's sweet spot. By logging your fatigue (rated 0 to 10) next to your protein intake and your strength benchmarks, you can see whether your tiredness lines up with low-protein, low-fuel days (a fueling problem you can fix) or with steadily falling strength (a possible muscle-loss signal worth raising with your clinician). Logging side effects, daily check-ins, and protein is part of Myo's free tier; the side-effect correlation charts and the muscle-loss trend flag are Premium. Tracking it across your dose week also shows whether fatigue clusters around dose day, which helps you plan your easier days. For more on what to record and why, see our guide to tracking GLP-1 side effects. Myo is a tracking and education tool, not medical advice, and it will not adjust your medication; it just makes the pattern visible so you and your provider can act on it.

The bottom line

Fatigue on a GLP-1 is usually the sum of eating far less, drinking less, and sometimes losing muscle, not just a direct drug effect. Start by hitting protein, hydrating with electrolytes, and keeping calories from cratering, and add resistance training to defend the muscle that keeps your energy up. If your tiredness comes with falling strength, treat it as a possible muscle-loss signal worth tracking and discussing with your clinician, and see your clinician for any fatigue that is sudden, severe, or does not improve.

References

• GLP-1 fatigue incidence (approximately 8 to 11 percent on semaglutide) and multifactorial nature: Wegovy Prescribing Information and Novo Nordisk medlink safety profile; Zepbound Prescribing Information.
• Lean-mass loss range (approximately 25 to 40 percent of weight lost): Tirzepatide SURMOUNT-1 DXA substudy, Diabetes, Obesity and Metabolism, 2025 (doi:10.1111/dom.16275); semaglutide SUSTAIN 8 (PMC6997246) and STEP 1 DXA analysis.
• Protein target (1.2 to 1.6 g/kg/day) and resistance training (at least 3 sessions/week): 2025 joint advisory from the Obesity Medicine Association, The Obesity Society, the American Society for Nutrition, and the American College of Lifestyle Medicine (PMC12264624; American Journal of Clinical Nutrition, 2025).
• Dehydration risk from reduced intake and GI fluid losses: Wegovy Prescribing Information.